Telehealth to increase access to transplant survivorship care for allogeneic stem cell transplant recipients regardless of distance to transplant center or neighborhood income.

Authors

Nausheen Ahmed

Nausheen Ahmed

Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS

Nausheen Ahmed , Sarah Fitzmaurice , Cherie Morey , Tania Torres , Darla Beckman , Siddhartha Ganguly , Rajat Bansal , Liza Rodriguez , Haitham Abdelhakim , Anurag K Singh , Sunil H. Abhyankar , Leyla Shune , Robert Kribs , Clint Devine , Jennifer Hanses , Muhammad Umair Mushtaq , Joseph McGuirk

Organizations

Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, University of Kansas Cancer Center, Westwood, KS, University of Kansas Hospital, Westwood, KS, University of Kansas Medical Center, Westwood, KS

Research Funding

No funding received
None

Background: Transplant Survivorship Clinic at our institution serves to improve outcomes and overall health of allogeneic transplant survivors. The COVID19 pandemic allowed for growth of telemedicine in our program. We examine the patterns of use of telehealth and hypothesize that the use of telemedicine allowed continued access to care compared to the era prior to availability. We compared our transplant survivorship clinic data from July- December 2020, when telehealth was well established and compared to July-December 2019. Methods: All patients seen by the survivorship team for end of treatment visits, graft versus host disease assessments and survivorship visits annually between July-December 2019 and July-December 2020 were included. Their zip codes were used to get direct distance to survivorship clinic, average drive time, driving distance and average household income as in zip-codes.com database. Results: Total number of office visits in July-Dec 2019 was 163 visits (0% via telehealth) and in July-Dec 2020 was 228 (66.2% via telehealth). All encounters (telehealth and office visits) were lower in July and August 2020 compared to July and August 2019 but higher in months of September -December 2020 compared to 2019. Comparing all encounters during 7/2019-12/2019 to 7/2020-12/2020, there was no statistically significant difference in median age (58yr vs 60 yr), gender (males: 58% vs 59%), race (non-white: 11% vs 8.7%), median years from transplant (4yr vs 3 yrs), median income of patient neighborhood ($63,735 vs $60,465) and average drive time to center from zip code (40 min vs 51min). Comparison of patients who chose telehealth vs. office visit is summarized in table. While there was no statistically significant difference in age when comparing all encounters in 2019 and 2020, those who chose telehealth were younger (55yrs vs 60yrs, p=0.003). Conclusions: There were higher patient encounters in the 2020 period compared to 2019. Most of these 2020 encounters were via were telehealth, demonstrating the role of telehealth in increasing access. Younger patients appeared to choose telehealth, but telehealth served patients up to the age of 77 yrs. Utilization of telehealth appeared to be irrespective of demographics such as gender, neighborhood income and driving distance to the center. Comparison of telehealth vs office visit for July-December 2019 and 2020.


Telehealth visits

(n=151)
Office visits

(n=240)
P value
Age (yrs), median (range)
55 (22-77)
60 (21-85)
0.003
Males, n (%)
91 (60)
137 (57)
0.599
Time since transplant (yrs), median (range)
4 (0.5-28)
3 (0.5-22)
0.156
No shows, n (%)
14 (6)
13 (9)
0.311
Neighborhood income ($), median (range)
64,4489 (24100-159021)
60,465 (25472-158857)
0.314
Average drive time to clinic (minutes), median (range)
44 (6-1061)
49 (0-1200)
0.760

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2021 ASCO Annual Meeting

Session Type

Publication Only

Session Title

Publication Only: Care Delivery and Regulatory Policy

Track

Care Delivery and Quality Care

Sub Track

Telemedicine/Remote Care

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr e13615)

DOI

10.1200/JCO.2021.39.15_suppl.e13615

Abstract #

e13615

Abstract Disclosures

Similar Abstracts

Abstract

2023 ASCO Quality Care Symposium

Loss to primary care provider follow-up among survivors five to seven years post-diagnosis.

First Author: Alexandra G. Peluso

First Author: Sarah A Birken

Abstract

2021 ASCO Quality Care Symposium

Patterns of virtual care among long-term cancer survivors.

First Author: Katherine Ramsey Gilmore